Febrile neutropenia in children

Area of Science:

• Pediatric Oncology
• Infectious Diseases
• Hematology

Background:

• Fever is common in neutropenic patients and often indicates infection, a major cause of mortality.
• Historically, prompt broad-spectrum antimicrobial therapy and diligent monitoring of infection sites significantly decreased mortality rates.
• Paediatricians have played a crucial role in standardizing the management of febrile neutropenia in children.

Purpose of the Study:

• To review the evolution of management strategies for febrile neutropenic patients, particularly children.
• To highlight current challenges and emerging trends in the diagnosis and treatment of infections in this vulnerable population.
• To discuss the need for updated diagnostic tools, risk assessment, and resource optimization.

Main Methods:

• Review of historical management concepts and contributions of paediatricians.
• Analysis of epidemiological trends, including the rise of Gram-positive bacteria and fungi.
• Discussion of advancements in antimicrobial agents and early discharge protocols.

Main Results:

• Significant mortality reduction achieved through early antimicrobial administration and understanding neutropenia's impact.
• Emerging trends show an increase in Gram-positive bacteria and fungal infections.
• New antibiotics have enabled shorter treatment regimens and early discharge for low-risk patients.

Conclusions:

• While management has improved, challenges remain in diagnostics, pathogen detection, and controlling nosocomial infections.
• Further research is needed on early antibiotic discontinuation, outpatient management, and risk stratification.
• Optimizing resource utilization and adapting to new epidemiological trends are critical for future care.